Octapharma Pharmazeutika Produktionsgesellschaft GmbH (OPG) Octapharma S.A.S.
PolandAll drugs from this manufacturer
-
The medicinal product is used for the treatment and prevention of bleeding in individuals suffering from hemophilia B, a condition in which blood takes longer to clot than it should due to a deficiency of factor IX.
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage human coagulation factor ix 100 j.m./ 1 ml ATC: B02BD04
-
The medicinal product is used for the treatment and prevention of bleeding in individuals suffering from hemophilia B, a condition resulting from a congenital deficiency of coagulation factor IX.
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage human coagulation factor ix 100 j.m./ 1 ml ATC: B02BD04